Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer

Original Article

Y. Cheng, D.R. Spigel, B.C. Cho, K.K. Laktionov, J. Fang, Y. Chen, Y. Zenke, K.H. Lee, Q. Wang, A. Navarro, R. Bernabe, E.L. Buchmeier, J.W.-C. Chang, Y. Shiraishi, S.S. Goksu, A. Badzio, A. Shi, D.B. Daniel, N.T.T. Hoa, M. Zemanova, H. Mann, H. Gowda, H. Jiang, and S. Senan

N Engl J Med 2024;391:1313-1327

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
10/09/2024
Course expires: 
10/10/2026

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.